Effective gene-virotherapy tumor mediated by the for complete eradication of combination of hTRAIL (TNFSF10) and plasminogen k5 | |
Liu, XY; Qiu, SB; Zou, WG; Pei, ZF; Gu, JF; Luo, CX; Ruan, HM; Chen, Y; Qi, YP; Qian, C | |
刊名 | MOLECULAR THERAPY
![]() |
2005 | |
卷号 | 11期号:4页码:531-541 |
关键词 | cancer gene therapy oncolytic adenovirus gene-virotherapy ZD55 hTRAIL k5 apoptosis angiogenesis |
通讯作者 | Liu, XY (reprint author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China.,xyliu@sibs.ac.cn ; qiyipeng@whu.edu.cn ; cqian@unav.es |
英文摘要 | Virotherapy with oncolytic viruses is a highly promising approach for cancer therapy. To improve further the therapeutic effect of oncolytic viruses, therapeutic genes have been incorporated into these types of vectors. In this study, we have inserted hTRAIL (approved gene symbol TNFSF10) into the ZD55 vector, which was based on deletion of the adenoviral E1B 55-kDa gene and could replicate in and lyse p53-deficient tumors. Our data shows that infection of colorectal carcinoma cells with ZD55-hTRAIL resulted in tumor cell death that was much greater than that induced by ZD55 vector or replication-defective adenovirus expressing hTRAIL. In contrast to these, ZD55-hTRAIL did not induce any cytopathic effect in normal cells. Treatment of established tumor with ZD55-hTRAIL resulted in dramatic inhibition of tumor growth in an animal model of colorectal carcinoma. However, when the established tumors were treated by coadministration of ZD55h-TRAIL and Ad-k5, we observed complete eradication of the established tumors in all animals treated with the combined therapy. This strong anti-tumor activity was due to the fact that two genes may act with compensative (or synergic) effect through different mechanisms to kill tumors. Therefore, targeting dual gene-virotherapy may be one of the best strategies for cancer therapy if two suitable genes are chosen. |
学科主题 | Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine |
类目[WOS] | Biotechnology & Applied Microbiology ; Genetics & Heredity ; Medicine, Research & Experimental |
关键词[WOS] | SELECTIVELY-REPLICATING ADENOVIRUS ; TRAIL-INDUCED APOPTOSIS ; HERPES-SIMPLEX-VIRUS ; ANTITUMOR-ACTIVITY ; IN-VIVO ; HEPATOCELLULAR-CARCINOMA ; DELETED ADENOVIRUS ; INTRATUMORAL COINJECTION ; CHEMOTHERAPEUTIC-AGENTS ; COLORECTAL-CARCINOMA |
收录类别 | SCI |
语种 | 英语 |
WOS记录号 | WOS:000227991700008 |
内容类型 | 期刊论文 |
版本 | 出版稿 |
源URL | [http://202.127.25.143/handle/331003/1899] ![]() |
专题 | 上海生化细胞研究所_上海生科院生化细胞研究所 |
推荐引用方式 GB/T 7714 | Liu, XY,Qiu, SB,Zou, WG,et al. Effective gene-virotherapy tumor mediated by the for complete eradication of combination of hTRAIL (TNFSF10) and plasminogen k5[J]. MOLECULAR THERAPY,2005,11(4):531-541. |
APA | Liu, XY.,Qiu, SB.,Zou, WG.,Pei, ZF.,Gu, JF.,...&Qian, C.(2005).Effective gene-virotherapy tumor mediated by the for complete eradication of combination of hTRAIL (TNFSF10) and plasminogen k5.MOLECULAR THERAPY,11(4),531-541. |
MLA | Liu, XY,et al."Effective gene-virotherapy tumor mediated by the for complete eradication of combination of hTRAIL (TNFSF10) and plasminogen k5".MOLECULAR THERAPY 11.4(2005):531-541. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论